Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00188929
Status:
COMPLETED
Last Update Posted:
2010-08-13
First Post:
2005-09-12
Brief Title:
Assessment of Treatment Response Using PETCT Scanner - Non Hodgkins Lymphoma
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
Spatio-temporal Response of Non-Hodgkins Lymphoma to External Beam Radiation Therapy Measuring 18F-Fluorodeoxyglucose FDG Uptake Using a Combined PETCT Scanner A Pilot Study
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study the treatment process will be closely monitored using a novel imaging technology a PETCT scanner PET stands for Positron Emission Tomography and in this case it will be combined with a conventional x-ray Computerized Tomography CT scan This is not a study of any particular form of treatment The treatment you receive will be the most appropriate standard treatment whether you are in the study or not
The goal of radiation therapy is to deliver a given amount of radiation dose to the area where there is a lymphoma tumour We are doing this study to see which part of the tumour reacts to the radiation treatment and which part does not react by monitoring the progress of your treatment with a combined PETCT scan In particular changes of the size and shape of the tumour that occur during the treatment can be detected and will be visible on the images These images will be thoroughly analysed The ability of the PETCT scanner to detect these changes during a course of radiation treatment will be the subject of this study We will also be able to see if this information will eventually relate to or predict whether lymphoma tumours will be completely eradicated by the treatment
The goal of radiation therapy is to deliver a given amount of radiation dose to the area where there is a lymphoma tumour We are doing this study to see which part of the tumour reacts to the radiation treatment and which part does not react by monitoring the progress of your treatment with a combined PETCT scan In particular changes of the size and shape of the tumour that occur during the treatment can be detected and will be visible on the images These images will be thoroughly analysed The ability of the PETCT scanner to detect these changes during a course of radiation treatment will be the subject of this study We will also be able to see if this information will eventually relate to or predict whether lymphoma tumours will be completely eradicated by the treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None